Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Source
Cell death and differentiation - ISSN 1350-9047-30:9 (2023) p. 2092-2103
Author(s)